Amgen Technology (Ireland) Unlimited Company
SpainAll medications by this manufacturer
-
Bekemv 300 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage ECULIZUMAB 300 mg -
Mvasi 25 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage BEVACIZUMAB 100 mg -
Mvasi 25 mg/ml concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage BEVACIZUMAB 400 mg -
Wezenla 130 mg concentrate for solution for infusion
Form: solution for infusion, concentrate
Active substance Dosage USTEKINUMAB 90 mg -
Wezenla 45 mg solution for injection
Form: solution for injection
Active substance Dosage USTEKINUMAB 45 mg -
Wezenla 45 mg solution for injection in pre-filled pen
Form: solution for injection in pre-filled pen
Active substance Dosage USTEKINUMAB 45 mg -
Wezenla 45 mg solution for injection in pre-filled syringe
Form: solution for injection
Active substance Dosage USTEKINUMAB 45 mg -
Wezenla 90 mg solution for injection in pre-filled pen
Form: solution for injection in pre-filled pen
Active substance Dosage USTEKINUMAB 90 mg -
Wezenla 90 mg solution for injection in pre-filled syringe
Form: solution for injection
Active substance Dosage USTEKINUMAB 90 mg